NCT06808477View on ClinicalTrials.gov

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

PHASE1RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

August 21, 2026

Study Completion Date

February 6, 2027

Conditions
Atopic Dermatitis
Interventions
DRUG

BBT001

BBT001 will be administered

DRUG

Placebo

Placebo will be administered

Trial Locations (5)

1010

RECRUITING

Optimal Clinical Trials Central Auckland, Grafton

2025

RECRUITING

Aotearoa Clinical Trials, Otahuhu

5018

RECRUITING

Pacific Clinical Research Network (PCRN) Wellington, Upper Hutt

6009

RECRUITING

Linear Clinical Research, Perth

0622

RECRUITING

Pacific Clinical Research Network (PCRN) - Auckland, Takapuna

Sponsors
All Listed Sponsors
lead

Bambusa Therapeutics

INDUSTRY